 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Current Price	$0.90
Prev Close	$0.943
Open	$0.9163
Dividend Yield	0.00%
50-Day Moving Average	$8.51
Beta	0.65
Avg. Volume	131,452.55
PE Ratio	-0.74

52-Week High	$12.58
52-Week Low	$0.6744
Market Capitalization	$9.4M
EPS	-$1.22
Price to Book	0.89
Revenue Per Employee	$313,333.33
Enterprise Value/EBITDA	-4.48

BLPH Bellerophon Therapeutics Inc

About

Feed

Fundamentals

News